Summary:
Florida Pulmonary Research Institute is conducting a study to assess the Safety, Efficacy, and Pharmacokinetics of PT003 in Subjects with Moderate to Very Severe COPD with and without a Valved Holding Chamber
Qualified Participants Must:
• Be 40 years of age or older
•
Be a current or previous smoker
•
Have a history of Kidney problems such as Chronic Kidney Disease or Renal Insufficiency
Qualified Participants May Receive:
Compensation for time and travel (Contact office for more information), Study-related exams, Study-related medications, and Study-related lab work.